10-Q Filing

AURINIA PHARMACEUTICALS INC. CIK: 1600620 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001628280-22-020820`
Period End Date	20220630
Filing Date	20220804
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	auph-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 72 Cash Flow Statement 68 Stockholders Equity 36

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value ($ per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par value ($ per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	141.60M	shares	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	141.89M	shares	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.56M	USD	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	141.89M	shares	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$151.63M	USD	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	141.60M	shares	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$272.35M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.90M	USD	Point-in-time
Short-term investments	`DebtSecuritiesCurrent`	$234.18M	USD	Point-in-time
Short-term investments	`DebtSecuritiesCurrent`	$240.10M	USD	Point-in-time
Accounts receivable, net	`AccountsAndOtherReceivablesNetCurrent`	$15.41M	USD	Point-in-time
Accounts receivable, net	`AccountsAndOtherReceivablesNetCurrent`	$18.17M	USD	Point-in-time
Inventories, net	`InventoryNet`	$19.33M	USD	Point-in-time
Inventories, net	`InventoryNet`	$25.86M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$17.42M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$12.51M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$513.32M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$453.19M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$11.84M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$12.36M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.42M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.18M	USD	Point-in-time
Acquired intellectual property and other intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$7.34M	USD	Point-in-time
Acquired intellectual property and other intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$8.40M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$5.08M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$5.38M	USD	Point-in-time
Total assets	`Assets`	$482.15M	USD	Point-in-time
Total assets	`Assets`	$543.37M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$32.38M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$34.95M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$4.64M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.29M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$953.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.06M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$34.63M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$40.65M	USD	Point-in-time
Deferred compensation and other non-current liabilities	`OtherLiabilitiesNoncurrent`	$16.32M	USD	Point-in-time
Deferred compensation and other non-current liabilities	`OtherLiabilitiesNoncurrent`	$15.95M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$7.68M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$7.43M	USD	Point-in-time
Total liabilities	`Liabilities`	$64.28M	USD	Point-in-time
Total liabilities	`Liabilities`	$58.38M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common shares - no par value, unlimited shares authorized, 141,892 and 141,600 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	`CommonStockValueOutstanding`	$1.18B	USD	Point-in-time
Common shares - no par value, unlimited shares authorized, 141,892 and 141,600 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	`CommonStockValueOutstanding`	$1.18B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$59.01M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$74.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-852.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.85M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-829.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-756.12M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$332.26M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$448.12M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$407.75M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$479.09M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$370.23M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$423.77M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$482.15M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$543.37M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Unrealized gain on available-for-sale securities, tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	-	USD	2 Qtrs
Unrealized gain on available-for-sale securities, tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	-	USD	1 Quarter
Unrealized gain on available-for-sale securities, tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	-	USD	1 Quarter
Unrealized gain on available-for-sale securities, tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	-	USD	2 Qtrs
Total revenue, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$28.19M	USD	1 Quarter
Total revenue, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.53M	USD	2 Qtrs
Total revenue, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$49.82M	USD	2 Qtrs
Total revenue, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$6.62M	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$308.00K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$1.60M	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$1.85M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$356.00K	USD	2 Qtrs
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$44.32M	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$96.73M	USD	2 Qtrs
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$51.53M	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$84.13M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$24.14M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$10.09M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$19.92M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$11.53M	USD	1 Quarter
Other (income) expense, net	`OtherOperatingIncomeExpenseNet`	$967.00K	USD	1 Quarter
Other (income) expense, net	`OtherOperatingIncomeExpenseNet`	$476.00K	USD	1 Quarter
Other (income) expense, net	`OtherOperatingIncomeExpenseNet`	$-958.00K	USD	2 Qtrs
Other (income) expense, net	`OtherOperatingIncomeExpenseNet`	$-804.00K	USD	2 Qtrs
Total cost of sales and operating expenses	`CostsAndExpenses`	$64.18M	USD	1 Quarter
Total cost of sales and operating expenses	`CostsAndExpenses`	$53.75M	USD	1 Quarter
Total cost of sales and operating expenses	`CostsAndExpenses`	$105.21M	USD	2 Qtrs
Total cost of sales and operating expenses	`CostsAndExpenses`	$123.69M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-35.99M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-47.13M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-73.87M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-97.68M	USD	2 Qtrs
Interest income	`InterestIncomeExpenseNonoperatingNet`	$483.00K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNonoperatingNet`	$142.00K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNonoperatingNet`	$745.00K	USD	2 Qtrs
Interest income	`InterestIncomeExpenseNonoperatingNet`	$314.00K	USD	2 Qtrs
Net loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-35.51M	USD	1 Quarter
Net loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-97.36M	USD	2 Qtrs
Net loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-46.99M	USD	1 Quarter
Net loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-73.13M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$19.00K	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$18.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$26.00K	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$9.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-35.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-97.39M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-73.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-47.01M	USD	1 Quarter
Unrealized (loss) gain on available-for-sale securities, net of tax of nil	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$13.00K	USD	2 Qtrs
Unrealized (loss) gain on available-for-sale securities, net of tax of nil	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-235.00K	USD	1 Quarter
Unrealized (loss) gain on available-for-sale securities, net of tax of nil	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$7.00K	USD	1 Quarter
Unrealized (loss) gain on available-for-sale securities, net of tax of nil	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-1.00M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-47.00M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-74.15M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-97.38M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-35.75M	USD	1 Quarter
Basic loss per share ($ per share)	`EarningsPerShareBasic`	$-0.76	USD	2 Qtrs
Basic loss per share ($ per share)	`EarningsPerShareBasic`	$-0.25	USD	1 Quarter
Basic loss per share ($ per share)	`EarningsPerShareBasic`	$-0.52	USD	2 Qtrs
Basic loss per share ($ per share)	`EarningsPerShareBasic`	$-0.37	USD	1 Quarter
Diluted loss per share ($ per share)	`EarningsPerShareDiluted`	$-0.52	USD	2 Qtrs
Diluted loss per share ($ per share)	`EarningsPerShareDiluted`	$-0.25	USD	1 Quarter
Diluted loss per share ($ per share)	`EarningsPerShareDiluted`	$-0.76	USD	2 Qtrs
Diluted loss per share ($ per share)	`EarningsPerShareDiluted`	$-0.37	USD	1 Quarter
Weighted-average common shares outstanding used in computation of basic loss per share (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	127.81M	shares	2 Qtrs
Weighted-average common shares outstanding used in computation of basic loss per share (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	141.73M	shares	1 Quarter
Weighted-average common shares outstanding used in computation of basic loss per share (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	141.73M	shares	2 Qtrs
Weighted-average common shares outstanding used in computation of basic loss per share (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	128.22M	shares	1 Quarter
Weighted-average common shares outstanding used in computation of diluted loss per share (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	141.73M	shares	2 Qtrs
Weighted-average common shares outstanding used in computation of diluted loss per share (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	128.22M	shares	1 Quarter
Weighted-average common shares outstanding used in computation of diluted loss per share (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	127.81M	shares	2 Qtrs
Weighted-average common shares outstanding used in computation of diluted loss per share (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	141.73M	shares	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-35.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-97.39M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-73.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-47.01M	USD	1 Quarter
Depreciation and amortization	`Depreciation`	$1.68M	USD	2 Qtrs
Depreciation and amortization	`Depreciation`	$1.26M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$17.08M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$15.57M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-2.51M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$2.90M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInReceivables`	$4.42M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInReceivables`	$2.76M	USD	2 Qtrs
Inventories, net	`IncreaseDecreaseInInventories`	$7.95M	USD	2 Qtrs
Inventories, net	`IncreaseDecreaseInInventories`	$3.45M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$1.99M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$4.91M	USD	2 Qtrs
Non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$517.00K	USD	2 Qtrs
Non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-229.00K	USD	2 Qtrs
Accounts payable, accrued and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.03M	USD	2 Qtrs
Accounts payable, accrued and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-6.24M	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-355.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$529.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-91.52M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-74.62M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$216.99M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$232.96M	USD	2 Qtrs
Proceeds from investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$164.65M	USD	2 Qtrs
Proceeds from investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$225.68M	USD	2 Qtrs
Upfront lease payment	`PaymentsToAcquireLeaseReceivables`	$11.84M	USD	2 Qtrs
Upfront lease payment	`PaymentsToAcquireLeaseReceivables`	-	USD	2 Qtrs
Purchase of non-current assets	`PaymentsToAcquireOtherProductiveAssets`	$118.00K	USD	2 Qtrs
Purchase of non-current assets	`PaymentsToAcquireOtherProductiveAssets`	$364.00K	USD	2 Qtrs
Additions to internal use-software implementation costs	`PaymentsForSoftware`	-	USD	2 Qtrs
Additions to internal use-software implementation costs	`PaymentsForSoftware`	$1.04M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.40M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-65.58M	USD	2 Qtrs
Proceeds from exercise of stock options and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$1.75M	USD	2 Qtrs
Proceeds from exercise of stock options and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$6.28M	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$30.00K	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.31M	USD	2 Qtrs
Cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.75M	USD	2 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-80.27M	USD	2 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-150.79M	USD	2 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.56M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$151.63M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$272.35M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.56M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$151.63M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$272.35M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.90M	USD	Point-in-time
Cash received for interest	`ProceedsFromInterestReceived`	$376.00K	USD	2 Qtrs
Cash received for interest	`ProceedsFromInterestReceived`	$528.00K	USD	2 Qtrs
Cash paid for taxes	`IncomeTaxesPaidNet`	$236.00K	USD	2 Qtrs
Cash paid for taxes	`IncomeTaxesPaidNet`	$779.00K	USD	2 Qtrs
Cash paid for amounts included in the measurement of lease liabilities	`CapitalLeaseObligationsIncurred`	$572.00K	USD	2 Qtrs
Cash paid for amounts included in the measurement of lease liabilities	`CapitalLeaseObligationsIncurred`	$128.00K	USD	2 Qtrs
Initial recognition of operating lease right-of-use asset	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$419.00K	USD	2 Qtrs
Initial recognition of operating lease right-of-use asset	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Cash, cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$121.56M	USD	Point-in-time
Cash, cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$151.41M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$224.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	-	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.56M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$151.63M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$272.35M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.90M	USD	Point-in-time

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balance (in shares)	`CommonStockSharesOutstanding`	141.89M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	141.60M	shares	Point-in-time
Balance	`StockholdersEquity`	$332.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$448.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$407.75M	USD	Point-in-time
Balance	`StockholdersEquity`	$479.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$370.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$423.77M	USD	Point-in-time
Shares issued on exercise of stock options and vesting of performance awards (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	77,000.00	shares	2 Qtrs
Shares issued on exercise of stock options and vesting of performance awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$117.00K	USD	1 Quarter
Shares issued on exercise of stock options and vesting of performance awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.28M	USD	1 Quarter
Shares issued on exercise of stock options and vesting of performance awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$522.00K	USD	2 Qtrs
Shares issued on exercise of stock options and vesting of performance awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.28M	USD	2 Qtrs
Issuance of common shares in conjunction with ESPP program	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.22M	USD	1 Quarter
Issuance of common shares in conjunction with ESPP program	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.22M	USD	2 Qtrs
Exercise of warrants	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$31.00K	USD	2 Qtrs
Shared-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.05M	USD	1 Quarter
Shared-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.75M	USD	1 Quarter
Shared-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.08M	USD	2 Qtrs
Shared-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.57M	USD	2 Qtrs
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeLossNetOfTax`	$7.00K	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeLossNetOfTax`	$-235.00K	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeLossNetOfTax`	$13.00K	USD	2 Qtrs
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeLossNetOfTax`	$-1.00M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-35.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-97.39M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-73.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-47.01M	USD	1 Quarter
Balance (in shares)	`CommonStockSharesOutstanding`	141.89M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	141.60M	shares	Point-in-time
Balance	`StockholdersEquity`	$332.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$448.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$407.75M	USD	Point-in-time
Balance	`StockholdersEquity`	$479.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$370.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$423.77M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.